Results 1 to 10 of about 15,382 (226)
Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare hemolytic disorder of acquired origin and is clinically manifested by chronic hemolysis, thromboses in various sites, and bone marrow failure.
Buddhi P Paudyal +4 more
doaj +6 more sources
Pathogenesis of Paroxysmal Nocturnal Hemoglobinuria.
Paroxysmal nocturnal hemoglobinuria (PNH) is a non-malignant clonal hematopoietic disorder. There are two components to the pathogenesis of PNH: (i) a mutant stem cell, (ii) expansion of the mutant clone. Component (i) is straightforward: there is almost
L. Luzzatto, S. Nakao
semanticscholar +3 more sources
Pegcetacoplan for Paroxysmal Nocturnal Hemoglobinuria.
Approximately a third of patients with paroxysmal nocturnal hemoglobinuria (PNH) remain transfusion dependent or have symptomatic anemia despite treatment with a C5 inhibitor.
G. Gerber, R. Brodsky
semanticscholar +3 more sources
Managing Fatigue in Patients with Paroxysmal Nocturnal Hemoglobinuria: A Patient-Focused Perspective
The most frequently reported symptom in patients with paroxysmal nocturnal hemoglobinuria (PNH), a disease characterized by complement mediated hemolysis and chronic anemia, is “fatigue”.
Esther Natalie Oliva +2 more
exaly +2 more sources
Paroxysmal Nocturnal Hemoglobinuria: Biology and Treatment
Paroxysmal nocturnal hemoglobinuria (PNH) is a nonmalignant clonal hematopoietic disorder characterized by the lack of glycosylphosphatidylinositol-anchored proteins (GPI-APs) as a consequence of somatic mutations in the phosphatidylinositol glycan ...
Carlos Bravo-Perez +3 more
doaj +2 more sources
Evolutionary dynamics of paroxysmal nocturnal hemoglobinuria. [PDF]
Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired clonal blood disorder characterized by hemolysis and a high risk of thrombosis, that is due to a deficiency in several cell surface proteins that prevent complement activation.
Nathaniel Mon Père +3 more
doaj +6 more sources
Paroxysmal nocturnal hemoglobinuria can rarely present as cerebral ischemia and stroke due to arterial thrombosis. However, it should be considered in a young patient with bone marrow failure features, systemic thromboses, and hemolysis.
Ayushma Acharya +3 more
doaj +1 more source
Consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria
Paroxysmal nocturnal hemoglobinuria is a chronic, multi-systemic, progressive and life-threatening disease characterized by intravascular hemolysis, thrombotic events, serious infections and bone marrow failure.
Rodolfo D. Cançado +8 more
doaj +1 more source
Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria.
BACKGROUND Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired disease characterized by chronic complement-mediated hemolysis. C5 inhibition controls intravascular hemolysis in untreated PNH but cannot address extravascular hemolysis ...
P. Hillmen +18 more
semanticscholar +1 more source
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare blood disease that leads to breakdown of the body’s red blood cells in the blood vessels (intravascular hemolysis). Many people with PNH have fatigue, which consists of tiredness and weakness.
D. Cella +7 more
semanticscholar +1 more source

